Current Funding
- Innovator Award (Fassler/Pinney/Privette Vinnedge) 07/01/2021 – 06/30/2022
Center for Environmental Genetics, NIEHS award P30ES006096; University of Cincinnati
“Airborne uranium exposure and incidence of breast cancer in a population living near a uranium refinery” - Mind, Brain, Behavior Research in Progress (Privette Vinnedge) 02/16/2021 – 02/15/2022
Cincinnati Children’s Hospital Medical Center
“Understanding the Roles of DEK as a Neuroprotective Factor in Alzheimer’s Disease” - Cancer Free Kids Pilot Grant (Johnstone/Privette Vinnedge) 09/01/2020 – 08/30/2021
“Investigating the role of ovarian hormones on secondary breast cancer risk following radiotherapy during puberty” - UC CCTST Pilot Collaborative Studies (Lee/Privette Vinnedge) 07/01/2020 – 06/30/2021
“Novel ROS-Responsive Doxorubicin Prodrug Delivery System for Cancer Treatment” - Marlene Harris-Ride Cincinnati Foundation (Vinnedge) 07/01/2020 - 06/30/2021
“Investigating the role of ovarian hormones on secondary breast cancer risk following radiotherapy during puberty” - L.I.F.E. Foundation (Solomon/Privette Vinnedge) 11/01/19- 10/31/21
“Exploring the Role of the Oncogene DEK as a Novel Player in Alzheimer’s Disease” - NIH award R37 CA218072-01A1(Privette Vinnedge) 02/08/18-01/31/25
“Mechanisms Coupling DEK to Oncogenesis”
